AAM Applauds HHS For Acknowledging Brand-Driven Cost Increases

Association Recommends Policy Solutions To Congress As Proposals To Lower Prices Unveiled

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.